The association between the peroxisome proliferator-activated receptor-gamma2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis
- PMID: 20179158
- PMCID: PMC2834889
- DOI: 10.1093/aje/kwp450
The association between the peroxisome proliferator-activated receptor-gamma2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis
Abstract
The peroxisome proliferator-activated receptor-gamma gene (PPARG) has been implicated in the etiology of type 2 diabetes mellitus and has been investigated in numerous epidemiologic studies. In this Human Genome Epidemiology review, the authors assessed this relation in an updated meta-analysis of 60 association studies. Electronic literature searches were conducted on September 14, 2009. Population-based cohort, case-control, cross-sectional, or genome-wide association studies reporting associations between the PPARG Pro12Ala gene variant (rs1801282) and type 2 diabetes were included. An updated literature-based meta-analysis involving 32,849 type 2 diabetes cases and 47,456 controls in relation to the PPARG Pro12Ala variant was conducted. The combined overall odds ratio, calculated by per-allele genetic model random-effects meta-analysis for type 2 diabetes and the Pro12Ala polymorphism, was 0.86 (95% confidence interval: 0.81, 0.90). The analysis indicated a moderate level of heterogeneity attributable to genuine variation in gene effect size (I(2) = 37%). This may reflect the variation observed between ethnic populations and/or differences in body mass index. Work on PPARG Pro12Ala should now focus on the observed heterogeneity in the magnitude of the association between populations. Further investigations into gene-gene and gene-environment interactions may prove enlightening.
Figures

Similar articles
-
[Meta-analysis of the association of Pro12Ala polymorphism of peroxisome proliferator activated receptor gamma gene with type 2 diabetes in Chinese Han population].Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2011 Dec;33(6):593-9. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2011. PMID: 22509538 Chinese.
-
Effects of Pro12Ala polymorphism in peroxisome proliferator-activated receptor-γ2 gene on metabolic syndrome risk: a meta-analysis.Gene. 2014 Feb 1;535(1):79-87. doi: 10.1016/j.gene.2013.07.087. Epub 2013 Sep 5. Gene. 2014. PMID: 24012868
-
Meta-analysis of association between the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 gene and diabetic retinopathy in Caucasians and Asians.Mol Vis. 2012;18:2352-60. Epub 2012 Sep 10. Mol Vis. 2012. PMID: 22993484 Free PMC article.
-
Association of PPARG Gene Polymorphisms Pro12Ala with Type 2 Diabetes Mellitus: A Meta-analysis.Curr Diabetes Rev. 2019;15(4):277-283. doi: 10.2174/1573399814666180912130401. Curr Diabetes Rev. 2019. PMID: 30207237 Review.
-
PPARG (Pro12Ala) genetic variant and risk of T2DM: a systematic review and meta-analysis.Sci Rep. 2020 Jul 29;10(1):12764. doi: 10.1038/s41598-020-69363-7. Sci Rep. 2020. PMID: 32728045 Free PMC article.
Cited by
-
Individualized therapy for type 2 diabetes: clinical implications of pharmacogenetic data.Mol Diagn Ther. 2012 Oct;16(5):285-302. doi: 10.1007/s40291-012-0002-7. Mol Diagn Ther. 2012. PMID: 23018631 Review.
-
Protective Effects of Red Guava on Inflammation and Oxidative Stress in Streptozotocin-Induced Diabetic Mice.Molecules. 2015 Dec 12;20(12):22341-50. doi: 10.3390/molecules201219831. Molecules. 2015. PMID: 26703532 Free PMC article.
-
Common genetic variants in peroxisome proliferator-activated receptor-γ (PPARG) and type 2 diabetes risk among Women's Health Initiative postmenopausal women.J Clin Endocrinol Metab. 2013 Mar;98(3):E600-4. doi: 10.1210/jc.2012-3644. Epub 2013 Feb 5. J Clin Endocrinol Metab. 2013. PMID: 23386649 Free PMC article.
-
PPARG: Gene Expression Regulation and Next-Generation Sequencing for Unsolved Issues.PPAR Res. 2010;2010:409168. doi: 10.1155/2010/409168. Epub 2010 Sep 8. PPAR Res. 2010. PMID: 20871817 Free PMC article.
-
PPARγ2 Pro12Ala Polymorphism is Associated in Children With Traits Related to Susceptibility to Type 2 Diabetes.Front Pharmacol. 2021 Nov 23;12:763853. doi: 10.3389/fphar.2021.763853. eCollection 2021. Front Pharmacol. 2021. PMID: 34887761 Free PMC article.
References
-
- Michalik L, Auwerx J, Berger JP, et al. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol Rev. 2006;58(4):726–741. - PubMed
-
- Spiegelman BM. PPAR-γ: adipogenic regulator and thiazolidinedione receptor. Diabetes. 1998;47(4):507–514. - PubMed
-
- Dubuquoy L, Dharancy S, Nutten S, et al. Role of peroxisome proliferator-activated receptor γ and retinoid X receptor heterodimer in hepatogastroenterological diseases. Lancet. 2002;360(9343):1410–1418. - PubMed
-
- Mukherjee R, Jow L, Croston GE, et al. Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARγ2 versus PPARγ1 and activation with retinoid X receptor agonists and antagonists. J Biol Chem. 1997;272(12):8071–8076. - PubMed
-
- Fajas L, Auboeuf D, Raspé E, et al. The organization, promoter analysis, and expression of the human PPARγ gene. J Biol Chem. 1997;272(30):18779–18789. - PubMed